ReVivo Medical Moves on Clinical Trial for Spinal Products

ReVivo Medical

ReVivo Medical agreed upon clinical trial parameters with FDA that define a pathway to commercial sales for its anterior cervical plate and interbody cages.

The company plans to begin enrollment for the 50-patient clinical study in 2Q21 at two U.S. centers. Study participants will receive ReVivo Medical’s next-generation anterior cervical...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us